Medicsight Share Discussion Threads

[oil pump] 25/5/2011 12:48

Onwards and Upwards, Excuse the Pun.

[gerri-c] 25/5/2011 12:29

L2 firmer.

[safman] 25/5/2011 12:05

With the FDA approval, i would suspect a lot more avenues have opened up regarding MDST.... There is however a lot of work to be done by the company, and i've said before, a colonoscopy is one of the most invasive procedures one can go through...

If that can be prevented using CAD.. (Wholly accurate) then clearly there is a very large market.. Its one for patience as well..

saffy..

[alpha534u] 24/5/2011 22:56

Medicsight PLC
("Medicsight" or "the Company")
FDA 510(k) Clearance to market ColonCAD™ API in the United States
Sales and commercialisation channels for ColonCAD now open
Medicsight PLC (AIM: MDST), an industry leader in the development of Computer-
Aided Detection (CAD) and medical image analysis software is pleased to announce
that the Medicsight ColonCAD™ API has received clearance from the U.S. Food
and Drug Administration (FDA). The clearance enables Medicsight to implement its
US sales and marketing strategy, a primary objective in the development of the
business since flotation.

Medicsight's ColonCAD is designed to assist radiologists during their review of CT
colonography (CTC – also known as "Virtual Colonoscopy") images by automatically
highlighting potential colorectal polyps (possible precursors to colorectal cancer) on
the CT image. The FDA clearance was supported by a large clinical trial involving 15
radiologist readers who each reviewed 112 patient CT colonography cases both
unassisted and assisted by ColonCAD. ColonCAD was used to support their
evaluation after they had made an initial review of all the CTC image data. Cases
were from a mixture of symptomatic and asymptomatic patients. The clinical trial
results demonstrated that, when assisted by ColonCAD, radiologists' accuracy for
detecting polyps of all sizes was significantly improved compared with unassisted
reading.

Professor Steve Halligan of University College Hospital in London, the Principal
Investigator for the trial, commented "The supporting clinical study clearly
demonstrates the positive effect of Medicsight's ColonCAD on the performance of
radiologists, and I believe that the results show the true potential of computer aided
detection as a tool which will provide significant benefit in clinical practice around the
world."

Allan Rowley, CEO of Medicsight, said "We are absolutely delighted to have reached
this important milestone for Medicsight and are excited about receiving FDA
clearance for ColonCAD™ API at a time when we anticipate that the demand for
Virtual Colonoscopy and CAD will rapidly increase. We look forward to the
commercialisation of Medicsight ColonCAD in the United States through our network
of advanced visualisation partners who are ready to deliver the ColonCAD solution to
end users. I would also like to thank the whole Medicsight team for their commitment
to the project, and bringing us to this key juncture."

Professor Perry Pickhardt from the University of Wisconsin School of Medicine &
Public Health, said "Having experienced the potential of Medicsight's ColonCAD in a
research environment I am very excited that the product will now be available for
clinical use in the US. I believe that ColonCAD will provide a real benefit and have a
positive impact on radiologists' review of virtual colonoscopy images."
CT colonography is a minimally invasive examination that captures digital images of
the patient's colon and generates detailed three-dimensional digital images of the
entire colorectum - enabling radiologists to thoroughly review the entire colon area.
Virtual Colonoscopy can be used for colon screening and also for the investigation of
symptoms of colonic disease.

In comparison to an optical colonoscopy examination, a Virtual Colonoscopy has the
benefits of: (a) being much less invasive; (b) has no requirement for intravenous
sedation or pain medication; and (c) requires no recovery time. With only half of the
100 million qualifying Americans aged fifty and over undergoing a colon cancer
screening test, the availability of tests that improve patient compliance is of vital
importance, and tools like Virtual Colonoscopy with Medicsight's ColonCAD that
improve test performance, are likely to be of significant benefit to patient care and
helping reduce colorectal cancer.

All taken from company website ref. FDA approval

[alpha534u] 24/5/2011 22:29

getting ready for some contract news ??? looks primed for that now with the FDA approval ....... HOLD ... sit back .... and watch !! ;-)) imho dyor etc ...

Medicsight

Medicsight

Medicsight
"To realise profitably the promise of innovative healthcare technologies to facilitate earlier and easier detection, diagnosis, and treatment of life threatening diseases"

Medicsight PLC is at the forefront of one of the highest growth and development sectors of medical imaging: Computer-Aided Detection (CAD). Its market-leading CAD software products have been developed using a large and population-diverse database of verified patient CT scan data. The software is designed to support clinicians in improving their detection and analysis of suspicious pathologies, which may be the early precursors of potential life threatening disease.
"With the impressive stand-alone sensitivity and the low false-positive rate, it is clear that the ColonCAD™ 4.0 software from Medicsight is ready to be applied in, and will add tremendous value to routine clinical practice including population-based screening programmes."
Perry J. Pickhardt, Professor of Radiology, University of Wisconsin

[cumnor] 24/5/2011 18:29

As i said grossly undervalued imo and someone wants in cheap with help of mms. The machinations of the past couple of days, where the share price retracrd 30pc from recent high was to squeeze out a few more pis (they had to work hard to do it) to allow the boys in. Thats how it works though so hoprfully due rerating over next few days. Imo

[mak600] 24/5/2011 17:50

hmm... late reported 2.5m at 9.6...

[adorling] 24/5/2011 16:26

Great rebound today and strength in buying

[cumnor] 24/5/2011 16:02

Small free float and i would be surprised to see any big investors wind down now the party has just begun, and some have gotten in at a pound plus. Hard to value but, with FDA backing in place, a 100ml dollar market cap at this early stage of a hightech/cancer diagnostic outfit's life would'nt be unusual in the States. Imo dyot

[xenawarriorprincess] 24/5/2011 15:52

10x100K around 3-3.30pm - interesting

[imabastard] 24/5/2011 15:51

Quite so .... :o)

[chickenchowmein] 24/5/2011 15:49

Looking very good

[gerri-c] 24/5/2011 15:38

Increasing the spread after the auction didn't seem to discourage buying.

[oil pump] 24/5/2011 11:01

Hope so g.
I made s crazy move. No research and went in blind. I made s classic error if trading and was down 25%.
After research it a fantasic opportunity now

[imabastard] 24/5/2011 09:03

"We also continue to work on the additional data requested by our reviewers at the Japanese Ministry of Health, Labour and Welfare (MHLW) and expect this to be submitted in Q2 this year."

.... so, anytime soon.

Snoz .... not sure of the Directors salary level .... they may still be paying back the £50k they each had (not sure of the split either) on their credit cards .... ;o)

[snozzy2] 24/5/2011 08:57

ImaB...but they were buying at 42p and waiting for FDA approval! Now they have approval, I'd be surprised if they didn't raid the piggy bank once more!!

[shifter2] 24/5/2011 08:56

hopefully kicking toshiba doors down to roll tech out tahts what we need

[imabastard] 24/5/2011 08:51

Could be that their piggy banks are light Snoz, given that they bought £150k's worth at 42p already ....

[snozzy2] 24/5/2011 08:34

At these prices and with the results just been published, one would expect the BOD to start buying a few shares, unless of course they are privy to price sensitive information!...Japan??

[chickenchowmein] 24/5/2011 07:53

Wonder if this will push down today? I'm looking to add and think today may be the day

[imabastard] 23/5/2011 16:33

You're right .... compared to the 15 million traded going up.